FY2026 · period end Mar '26 · from the 10-K filed Jun 26, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Revenue | $0.07B | $0.08B | $0.05B | $0.07B | $0.06B |
| Gross Profit | — | — | — | — | $0.06B |
| Operating Income | negative: -$0.02B | $0.01B | negative: -$0.02B | negative: -$0.01B | negative: -$0.00B |
| Net Income | negative: -$0.01B | $0.00B | negative: -$0.02B | negative: -$0.01B | $0.00B |
| EPS (Diluted) | negative: -$0.49 | $0.16 | negative: -$1.78 | negative: -$1.13 | $0.20 |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Total Assets | $0.13B | $0.07B | $0.06B | $0.09B | $0.10B |
| Total Liabilities | $0.09B | $0.03B | $0.03B | $0.05B | $0.06B |
| Stockholders' Equity | $0.04B | $0.04B | $0.03B | $0.04B | $0.04B |
| Cash & Equivalents | $0.00B | $0.01B | $0.01B | $0.01B | $0.01B |
| Total Debt | — | — | — | — | — |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.03B | $0.02B | negative: -$0.01B | negative: -$0.01B | $0.00B |
| Capital Expenditures | — | — | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | — | — | negative: -$0.01B | negative: -$0.01B | $0.00B |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | 98.5% |
| Operating Margin | negative: -0.2% | 0.1% | negative: -0.3% | negative: -0.1% | negative: -1.7% |
| Net Margin | negative: -0.1% | 0.0% | negative: -0.4% | negative: -0.1% | 4.1% |
| Return on Equity | negative: -21.3% | 10.8% | negative: -59.7% | negative: -24.2% | 5.5% |
| Return on Assets | negative: -8.5% | 5.5% | negative: -27.9% | negative: -10.1% | 2.2% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Who is buying and selling Cineverse Corp. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CNVS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on CNVS and publish the result to your public profile.
Ask about Cineverse Corp.
Continue in Workspace — cited answers on CNVS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001193125-26-349428 | Jun 30, 2026 | Aug 13, 2026 | Aug 13, 2026 20:45 UTC | EDGAR |
| 10-K | 0001193125-26-284027 | Mar 31, 2026 | Jun 26, 2026 | Jun 26, 2026 12:50 UTC | EDGAR |
| 10-Q | 0001193125-26-055008 | Dec 31, 2025 | Feb 17, 2026 | Feb 17, 2026 22:01 UTC | EDGAR |
| 10-Q | 0001193125-25-283349 | Sep 30, 2025 | Nov 14, 2025 | Nov 14, 2025 22:31 UTC | EDGAR |
| 10-Q | 0000950170-25-109033 | Jun 30, 2025 | Aug 14, 2025 | Aug 14, 2025 21:01 UTC | EDGAR |
| 10-K | 0000950170-25-091741 | Mar 31, 2025 | Jun 30, 2025 | Jun 30, 2025 21:27 UTC | EDGAR |
| 10-Q | 0000950170-25-021401 | Dec 31, 2024 | Feb 14, 2025 | Feb 14, 2025 22:00 UTC | EDGAR |
| 10-Q | 0000950170-24-127165 | Sep 30, 2024 | Nov 14, 2024 | Nov 14, 2024 22:00 UTC | EDGAR |
| 10-Q | 0000950170-24-097132 | Jun 30, 2024 | Aug 14, 2024 | Aug 14, 2024 20:50 UTC | EDGAR |
| 10-K | 0000950170-24-079718 | Mar 31, 2024 | Jul 1, 2024 | Jul 1, 2024 20:55 UTC | EDGAR |
| 10-Q | 0000950170-24-015311 | Dec 31, 2023 | Feb 14, 2024 | Feb 14, 2024 21:50 UTC | EDGAR |
| 10-Q | 0000950170-23-063839 | Sep 30, 2023 | Nov 14, 2023 | Nov 14, 2023 22:05 UTC | EDGAR |
Direct links to SEC EDGAR. CNVS has additional filings available on the SEC site.
6 numbers Cineverse Corp. later changed — same XBRL tag, both filings linked.
Revenue from Contract with Customer, Excluding Assessed Tax·Q1 2020
Major restatementwas$9K
Revised up in a 10-Q. Any P/S built on the original was 88.2% too high.
Revenues·3 months to Mar 2017
Major restatementwas$19.6M
Revised up in a 10-K. Any P/S built on the original was 78.3% too high.
Revenues·3 months to Mar 2016
Major restatementwas$23.2M
Revised up in a 10-K. Any P/S built on the original was 77.8% too high.
Net Income (Loss) Attributable to Parent·Q1 2012
Major restatementwas-$5.2M
Revised up in a 10-Q.
Net Income (Loss) Available to Common Stockholders, Basic·Q1 2012
Major restatementwas-$5.2M
Revised up in a 10-Q.
Operating Income (Loss)·Q1 2011
Major restatementwas$2.3M
Revised up in a 10-Q.
CNVS is not the only one.
See every restatement we've found across the market — or get an alert the next time CNVS revises a number.
Restatements are detected by comparing every vintage of a fact across all of Cineverse Corp.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CNVS's most significant revisions, and a figure absent from it has not been certified as unrevised.
